Peter Svensson
91 – 100 of 146
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
Prasugrel 5-mg in the very elderly attenuates platelet inhibition but maintains non-inferiority to prasugrel 10-mg in non-elderly patients: The GENERATIONS trial, a pharmacodynamic and pharmacokinetic study in stable coronary artery disease patients.
- Contribution to journal › Article
-
Mark
Dabigatran in clinical practice - One-year experience at Skåne University Hospital.
- Contribution to journal › Letter
-
Mark
Homozygous factor V Leiden and double heterozygosity for factor V Leiden and prothrombin mutation.
- Contribution to journal › Article
- 2012
-
Mark
Mortality and Inherited Thrombophilia: results from the European Prospective Cohort on Thrombophilia (EPCOT).
- Contribution to journal › Article
-
Mark
Computerised assistance for warfarin dosage - Effects on treatment quality
- Contribution to journal › Article
-
Mark
Evaluation of recurrent venous thromboembolism in patients with Factor V Leiden mutation in heterozygous form.
- Contribution to journal › Article
-
Mark
Triple antithrombotic therapy following an acute coronary syndrome: prevalence, outcomes and prognostic utility of the HAS-BLED score.
- Contribution to journal › Article
-
Mark
Ateroskleros och trombogenes
(2012)
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Ateroskleros och trombogenes
(2012) p.21-27
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2011
-
Mark
Risk factors for hemorrhage during local intra-arterial thrombolysis for lower limb ischaemia
- Contribution to journal › Article
